Search results
15 wrz 2022 · Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anticoagulation.
- View EPUB
PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...
- Linda S. Williams
Many diseases with specific indications for specific...
- PDF/Epub
PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...
- Trial
Background—The Randomized Evaluation of Long-term...
- Results From the GEIST
Left ventricular (LV) thrombus formation is a well‐known...
- Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
Objective: Takotsubo syndrome (TTS) is characterized by...
- Stroke
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Peripartum Cardiomyopathy
Peripartum cardiomyopathy is a potentially life-threatening...
- View EPUB
1 maj 2023 · Echocardiographic outcomes evaluated included resolution of thrombus size and time to complete thrombus resolution. Clinical outcomes included mortality, thromboembolic complications, and bleeding complications.
Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).
Here we propose an algorithmic approach to the diagnosis and management of left ventricular (LV) thrombus following acute myocardial infarction (AMI) that begins with transthoracic echocardiography (TTE) with contrast within 24 hours of index myocardial infarction (MI).
25 sty 2023 · Left ventricular thrombus (LVT) is a known complication of acute myocardial infarction (AMI) and other cardiomyopathies. LVT increases the risk of stroke and systemic embolism, hence treatment with oral anticoagulation is indicated.
, Hesham Elmariah. , Yesha Patel. , Ali Omar. , Becky Naoulou. , John T. Fox. , and. Yumiko Kanei. JACC. 2022 Mar, 79 (9_Supplement) 361. PDF. Download Citation. Sections. About. Background: Management of LV thrombus (LVT) is challenging and crucial to prevent the potential development of thromboembolic complications such as stroke.
23 wrz 2022 · On the basis of limited data, patients with nonischemic cardiomyopathy with LV thrombus should be treated with OAC for at least 3–6 months, with discontinuation if LV ejection fraction improves to >35% (assuming resolution of the LV thrombus) or if major bleeding occurs.
